Who Paid My Doc
Frank McAllister
Allergy & Immunology Las Vegas, NV Doctor of Osteopathy
NPI 1114955762 CMS profile 141192
7435 W Azure Dr, Suite 190, Las Vegas, NV 89130
General payments
$905
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Frank McAllister of Las Vegas, NV is reported in the CMS Open Payments database as having received $905 across 58 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 36th percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $239 | 13 | |
| 2021 | General | $402 | 31 | |
| 2020 | General | $205 | 11 | |
| 2019 | General | $58 | 3 |
Beside peers
- Frank McAllister
- Allergy & Immunology median
- Middle half of Allergy & Immunology
- National median
In program year 2025, general payments to Frank McAllister were reported at $0. Among 336 Allergy & Immunology profiles paid that year, the median was $682 and the middle half received between $143 and $2,317.
Show as a table
| Year | Frank McAllister | Allergy & Immunology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $58 | $378 | $115–$1,178 | $163 |
| 2020 | $205 | $303 | $75–$1,581 | $114 |
| 2021 | $402 | $407 | $122–$1,475 | $132 |
| 2022 | $239 | $357 | $120–$1,340 | $149 |
| 2023 | $0 | $445 | $124–$1,536 | $160 |
| 2024 | $0 | $541 | $129–$1,763 | $164 |
| 2025 | $0 | $682 | $143–$2,317 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
178
Drug cost
$1,296
Branded share of claims
40.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 58 | $437 | |
| Fluticasone Propionate | Generic | 44 | $363 | |
| Methylprednisolone | Generic | 23 | $183 | |
| Ciprofloxacin Hcl | Generic | 24 | $132 | |
| Mupirocin | Generic | 15 | $119 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 14 | $62 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 27 billing codesPaid by Medicare
$4,409
Medicare patients
82
Services billed
200
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 45% | |
| Diabetes | 32% | |
| Ischemic heart disease | 27% | |
| Chronic kidney disease | 24% | |
| Depression | 17% | |
| Cancer | 16% | |
| COPD | 15% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
58 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Allergy & Immunology in Nevada
Related records
Allergy & Immunology in Nevada
Practitioners in the same specialty and state, ranked by reported value.
All Allergy & Immunology
Everyone recorded under this specialty, nationwide.
Doctors in Nevada
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.